Global Non-Oncology Precision Medicine Market by Ecosystem, Application, and Region – Forecast 2017 to 2027

Report ID: GMRI0017 | Published Date: Jul 2021 | Report Format: PDF

Price : $3500

Market Overview:

The global non-oncology precision medicine market was valued at approximately USD 45.0 billion in 2020 and is projected to grow to USD 130.2 billion by 2027, registering a compound annual growth rate (CAGR) of 16.4% during the forecast period of 2021–2027.

Precision medicine is a tailored approach to healthcare that considers individual genetic makeup, environment, and lifestyle when determining treatment. While it has been widely associated with cancer care, precision medicine is increasingly being applied to other health conditions such as genetic disorders, immune system deficiencies, and infectious diseases. Since patients with similar conditions may respond differently to the same treatment, precision medicine aims to customize therapies based on specific genetic and biological factors.

The expansion of precision medicine beyond oncology is driven by several key factors. These include the increasing prevalence of infectious and respiratory illnesses, the growing demand for individualized treatment strategies, and significant investments by industry stakeholders. Between 2016 and 2020, the sector saw notable activity: around four major funding rounds, 59 collaborations and partnerships, 44 new product launches and upgrades, 18 mergers and acquisitions, 26 regulatory or legal events, and six strategic business expansions.

Global Non-Oncology Precision Medicine Market Segmentation

By Ecosystem Type

Applied Sciences
Precision Diagnostics
Digital Health & Information Technology
Precision Therapeutics

By Application

Infectious Diseases
Neurology
Endocrinology
Cardiovascular
Others

By Geographical Region

North America
Europe
Asia-Pacific
South America
Middle East & Africa

Market Segmentation Insights

Ecosystem Type
Within the ecosystem segments, applied sciences held the largest market share in 2020 and is expected to maintain its dominance throughout the forecast period. Ongoing scientific discoveries and technological innovations continue to drive the advancement of personalized medicine, creating promising opportunities for both industry players and patients.

Application
Among applications, the infectious diseases segment is projected to lead the market. The global rise in infectious diseases—exemplified by the COVID-19 pandemic, which caused over half a million deaths by August 2020—has compelled governments worldwide to increasingly adopt precise diagnostic and therapeutic approaches to address the escalating disease burden.

Geographical Region
Geographically, North America accounted for the largest share of the non-oncology precision medicine market in 2020. The region’s leadership is attributed to its advanced healthcare infrastructure, sophisticated technologies, and growing patient population affected by various diseases.

Meanwhile, the Asia-Pacific region is experiencing rapid growth in precision medicine technologies. Countries like China, India, Japan, and Australia are investing heavily in innovation and research to improve patient care through personalized medicine solutions.

Market Dynamics

Drivers

Increased availability of targeted therapies and reduction of trial-and-error prescriptions
Decreased risk of adverse drug reactions
Declining costs of genome sequencing
Rising prevalence of chronic diseases

Restraints

Limited awareness of precision medicine applications beyond cancer
Ambiguity in regulatory frameworks concerning personalized therapies

Opportunities

Growing research and development efforts accelerating market entry
Robust product pipelines
Increasing approvals from regulatory bodies such as the FDA

Challenges

Incomplete understanding of molecular mechanisms and interactions
Integration challenges of electronic health records (EHR)

Impact of COVID-19 on Non-Oncology Precision Medicine

The COVID-19 pandemic has had widespread effects on global industries, impacting economic growth, public health, and mental wellbeing. The healthcare sector was significantly affected; however, the non-oncology precision medicine market remained resilient. In fact, the pandemic accelerated demand for technological advancements, adaptability, and transformation within this space.

The surge in respiratory illnesses highlighted the urgent need for precise therapeutic options, positioning non-oncology precision medicine as a critical solution. Although COVID-19 did not directly affect precision medicine therapies, it created new opportunities to expand treatment applications for infectious, cardiovascular, and other diseases requiring post-pandemic care.

Key Market Trends

The report further offers an in-depth examination of emerging trends shaping the global non-oncology precision medicine market, including technological innovations, strategic collaborations, and evolving regulatory landscapes.

Recent Developments and Investments

The report provides a detailed analysis of the latest news and investment activities in the non-oncology precision medicine sector:

In June 2021, Weill Cornell Medicine launched the “We’re Changing Medicine” campaign, committing USD 1.5 billion to advance innovations in biomedical fields such as artificial intelligence, precision medicine, machine learning, and genomics.
In June 2020, Infosys introduced a SAP-based Personalized Medicine Solution for pharmaceutical companies, leveraging blockchain, analytics, and IoT technologies to enhance supply chain management, patient care, and regulatory compliance.

Company Profiles and Competitive Intelligence

Key companies driving the non-oncology precision medicine market include:

Abbott Laboratories
Agilent Technologies
Asuragen
Partek Incorporated
Almac Group
Bristol Myers Squibb
bioMérieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation
GlaxoSmithKline plc.
AstraZeneca PLC
Invitae Corporation
Opko Health, Inc.
Laboratory Corporation of America Holdings
Pacific Biosciences of California, Inc.

Unique Insights Offered by This Report

Comprehensive value chain analysis
Opportunity mapping within the sector
Sector snapshot highlighting key metrics
Positioning matrix of leading players
Overview of the regulatory environment
Benchmarking heat map of adopted strategies
Market trends analysis
Impact assessment of COVID-19
Product comparisons
Evaluation of pre- and post-COVID-19 effects on the non-oncology precision medicine market
Detailed competitive landscape

AI and Machine Learning Integration, American Marketing Association (AMA), Associate Consultant, Associate Partner (Consulting), Brand Awareness/Perception Studies, Branding Research, Case Studies, Competitor Analysis, Competitor Research, Comprehensive Approach, Consultant, Consulting/Consultancy, Consistency and Brand Alignment, Cost-Effectiveness, Council of American Survey Research (CASRO), Customer Journey Maps (CJM), Customer Research, Customer Understanding, Data Analysis, Data Collection, Digital Transformation Consulting, Director of Market Research, Economic Consulting, Efficiency, Enhanced Decision-Making, ESG (Environmental, Social, Governance) Consulting, ESOMAR, Exploratory Research, Financial Advisory, Flexible Models and Specialization (Consulting), Human Element (Consulting), Human Resources (HR) Consulting, Implementation Consulting, In-house Market Research Capabilities, Insights Analyst, Insights Generation, Integrated Services, Intern (Consulting), IT/Technology Consulting, Manager (Consulting), Market Research, Market Research Analysts, Market Research Reports, Market Segmentation Reports, Marketing Data Analyst, Marketing Research Association (MRA), Observational Research, Optimized Resource Allocation, Partner (Consulting), Personalized Solutions (Consulting), Primary Research, Problem Solving, Product Research, Product Research Analyst, Qualitative Research, Qualitative Research Assistant, Qualitative Research Consultants Association (QRCA), Quantitative Research, Real-Time Data Analytics, Remote Work (Consulting), Risk Consulting, Risk Reduction, Secondary Research, Senior Associate Consultant, Senior Manager (Consulting), Social Media Listening, Specific Research, Strategic Plans, Strategy Consulting, Sustainability Consulting, SWOT Analysis, Target Market/Audience.

Introduction
1. Product Outline
2. What is non-oncology Precision Medicine
3. Different Types of Non-Oncology Precision Medicines
4. Covid -19 Impact
5. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunities
  4. Threats
6. Technology Overview
7. Patent Analysis
Regulatory Landscape for Non-Oncology Precision Medicines
1. Regulations and Standards
Non-Oncology Precision Medicines Market Pricing Analysis
1. Price Analysis of Precision Medicine
Non- Oncology Precision Medicine Market by Ecosystem
1. Applied Sciences
2. Precision Diagnostics
3. Digital Health & Information Technology
4. Precision Therapeutics
Non-Oncology Precision Medicine Market by Applications
1. Infectious diseases
2. Neurology
3. Endocrinology
4. Cardiovascular
5. Others
Non- Oncology Precision Medicine Market by Region
1. North America
  1. US
  2. Canada
2. Europe
  1. Germany
  2. UK
  3. France
  4. Spain
  5. Netherlands
  6. Rest Of Europe
3. Asia Pacific
  1. China
  2. India
  3. Japan
  4. Australia
  5. Rest Of Asia Pacific
4. Middle East and Africa
5. South America
Key Strategic Insights
New Raw Material Sources
1. New Applications
2. Emerging Technologies
3. Opportunity mapping
4. Critical Success Factors
5. Environmental Impact and sustainability issues
6. Consumer preferences
7. Key Market Trends / Recent Developments
Competitive Scenario
Mergers and Acquisitions
1. Investments
2. Joint Ventures
3. New Product Launches
4. Ranking of Key Players
Key Global Players
1. Abbott Laboratories
2. Agilent Technologies
3. Asuragen
4. Partek Incorporated
5. Almac Group
6. Bristol Myers Squibb
7. bioMérieux SA
8. Bio-Rad Laboratories, Inc
9. Danaher Corp.
10. GlaxoSmithKline plc.
11. AstraZeneca PLC

Report Research Methodology

At our global market research firm, we use advanced analytical tools and methodologies to deliver precise, data-driven insights. Our experienced analysts provide comprehensive research reports equipped with actionable strategies that can generate measurable business outcomes. We use a combination of top-down and bottom-up approaches to examine the market from multiple perspectives.

This dual approach allows for thorough segmentation and enables a deep-dive analysis of each individual market segment.

We also adopt data triangulation methods to cross-validate data from various sources. This ensures our clients receive well-rounded, accurate market insights. The key elements of our research methodology include:

Exploratory Data Mining

We begin with an extensive data collection process, gathering raw information that is rigorously filtered to retain only what is relevant. This filtered data is verified for authenticity before being used further. In addition to new data, we also integrate validated insights from our internal database of previous reports and research studies.

Our extensive in-house data repository, along with access to reliable paid databases, forms the foundation for robust research outputs.

Market Landscape Understanding

To gain a holistic view of the market, we analyze both historical data and current trends. Our sources include industry stakeholders such as distributors and suppliers, in addition to credible government portals and official reports.

We also utilize qualitative inputs such as journal publications, survey responses, and customized questionnaires. Emphasis is placed on analyzing key industry dynamics like drivers, restraints, and economic factors. All collected data undergoes stringent validation and is refined using best-in-class cross-verification techniques.

Data Collection Matrix

Research Tools & Models

We use simulation-based models and business intelligence (BI) dashboards to deliver real-time statistics and predictive insights. Clients also benefit from our online reporting tools, which offer access to KPIs, brand performance data, and embedded analytics.

Our research models are tailored based on each client's unique needs. The datasets include market dynamics, technological developments, pricing trends, and application landscapes, all of which feed into forecasting models.

We provide both short-term econometric analysis and long-term technology market forecasts, helping clients seize emerging opportunities. By comparing variables like technological advancement, product innovation, and capital flow, we can assess their impact over the forecast period.

Our analysts apply correlation, regression, and time-series analysis to provide reliable business forecasts. They also account for external factors such as regulatory landscapes, technological shifts, and economic indicators.

We analyze demographic data regionally and then consolidate it to provide a “glo-cal” (global + local) perspective. Every report is curated to deliver actionable insights with precision and speed. Our team closely collaborates with clients throughout the research process—from market exploration to strategy execution.

Forecasting Parameters

We assign different weightages to forecasting factors to quantify their influence on market dynamics. This ensures a transparent and measurable projection of market trends. Parameters include:

Key market drivers and restraints, including their current and projected impact
Raw material availability and pricing trends
Regulatory frameworks and expected policy changes
Current and future production capacity through 2027

Primary Validation

The final stage of the research process involves market forecasting and expert validation. In-depth interviews are conducted with senior decision-makers and industry veterans to verify the research assumptions and findings.

We perform face-to-face and telephonic interviews with professionals across the value chain—suppliers, distributors, vendors, and end-users—to ensure unbiased and well-rounded insights. With a multilingual team, we conduct global interviews seamlessly.

These expert interactions enrich our reports with real-world context, enhancing their reliability and credibility. Our trained researchers engage with Key Industry Participants (KIPs), including:

Established market leaders
Raw data providers
Network partners like resellers and distributors
End-user representatives

Objectives of Primary Research

To confirm the accuracy and relevance of collected data
To understand current market conditions and forecast future trends

Industry Analysis Matrix